Dietary and Non-Dietary Modulators of Cognitive Function.
1Institute of Anatomy, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.
Nutrients
|July 14, 2023
Summary
Genetic and environmental factors significantly impact long-term brain function. Understanding these influences is key to brain health research and potential interventions.
Area of Science:
- Neuroscience and Genetics
- Epigenetics and Environmental Health
Background:
- Long-term brain function is influenced by a complex interplay of internal and external factors.
- Genetic predispositions represent a significant internal factor affecting neurological outcomes.
- Epigenetic modifications and environmental exposures constitute crucial external influences.
Discussion:
- Investigating the combined effects of genetic, epigenetic, and environmental factors is essential for a comprehensive understanding of brain health.
- The interaction between nature (genetics) and nurture (environment) plays a critical role in shaping cognitive and neurological trajectories.
- Longitudinal studies are needed to elucidate the long-term consequences of these factors on brain plasticity and function.
Key Insights:
- Both inherited genetic variations and acquired epigenetic changes contribute to individual differences in brain function.
- Environmental factors, from early development through adulthood, can modify gene expression and impact brain health.
- A multifactorial approach is necessary to fully grasp the mechanisms underlying brain aging and disease.
Outlook:
- Future research should focus on personalized medicine approaches informed by an individual's genetic and environmental profile.
- Developing targeted interventions to mitigate negative environmental impacts on brain function is a promising avenue.
- Further exploration into the epigenetic mechanisms linking environment and brain health could reveal novel therapeutic targets.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
159
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
159
01:22Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
255
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
255
01:30Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
01:25Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K